Abstract
PurposeTo automatically assess the aggressiveness of prostate cancer (PCa) lesions using zonal‐specific image features extracted from diffusion weighted imaging (DWI) and T2W MRI.MethodsRegion of interest was extracted from DWI (peripheral zone) and T2W MRI (transitional zone and anterior fibromuscular stroma) around the center of 112 PCa lesions from 99 patients. Image histogram and texture features, 38 in total, were used together with a k‐nearest neighbor classifier to classify lesions into their respective prognostic Grade Group (GG) (proposed by the International Society of Urological Pathology 2014 consensus conference). A semi‐exhaustive feature search was performed (1–6 features in each feature set) and validated using threefold stratified cross validation in a one‐versus‐rest classification setup.ResultsClassifying PCa lesions into GGs resulted in AUC of 0.87, 0.88, 0.96, 0.98, and 0.91 for GG1, GG2, GG1 + 2, GG3, and GG4 + 5 for the peripheral zone, respectively. The results for transitional zone and anterior fibromuscular stroma were AUC of 0.85, 0.89, 0.83, 0.94, and 0.86 for GG1, GG2, GG1 + 2, GG3, and GG4 + 5, respectively.CONCLUSIONThis study showed promising results with reasonable AUC values for classification of all GG indicating that zonal‐specific imaging features from DWI and T2W MRI can be used to differentiate between PCa lesions of various aggressiveness.
Highlights
Prostate cancer (PCa) remains the most common noncutaneous cancer among men and one of the most common causes of cancer‐ related deaths.[1]
The histopathological aggressiveness of PCa is graded by the Gleason Score (GS), which is a powerful predictor of progression, mortality, and outcomes of the disease.[3]
Due to the random sampling when obtaining prostate biopsies, the GS differs from that determined after radical prostatectomy (RP).[3,4]
Summary
Prostate cancer (PCa) remains the most common noncutaneous cancer among men and one of the most common causes of cancer‐ related deaths.[1]. Due to the random sampling when obtaining prostate biopsies, the GS differs from that determined after radical prostatectomy (RP).[3,4] At the time of diagnosis, the ability to distinguish between indolent, intermediate, and aggressive PCa is limited, leading to incorrect risk stratification and possible over‐ and undertreatment.[5]
Published Version (Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have